CN101501033B - 对淀粉状蛋白具有亲和性的化合物 - Google Patents
对淀粉状蛋白具有亲和性的化合物 Download PDFInfo
- Publication number
- CN101501033B CN101501033B CN2007800298930A CN200780029893A CN101501033B CN 101501033 B CN101501033 B CN 101501033B CN 2007800298930 A CN2007800298930 A CN 2007800298930A CN 200780029893 A CN200780029893 A CN 200780029893A CN 101501033 B CN101501033 B CN 101501033B
- Authority
- CN
- China
- Prior art keywords
- compound
- equivalent
- pyridine
- imidazo
- amyloid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/041—Heterocyclic compounds
- A61K51/044—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
- A61K51/0455—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Physics & Mathematics (AREA)
- Medicinal Chemistry (AREA)
- Optics & Photonics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Abstract
Description
化合物名称 | 通用名 |
化合物1 | 2-[4′-(3″-氟丙氧基)苯基]-6-甲氧基咪唑并[1,2-a]吡啶 |
化合物2 | 2-[4′-(3″-氟丙氧基)苯基]-6-羟基咪唑并[1,2-a]吡啶 |
化合物3 | 2-[4′-(3″-氟丙氧基)苯基]咪唑并[1,2-a]吡啶 |
化合物4 | 2-[4′-(3″-[18F]氟丙氧基)苯基]-6-甲氧基咪唑并[1,2-a]吡啶 |
实验 | 用于评价的化合物 | IC50%值(nmol/L) |
比较例1 | 3′-I-BTA-0 | 10.1 |
比较例2 | 刚果红 | >1000 |
比较例3 | 硫磺素T | >1000 |
比较例4 | 6-Me-BTA-2 | 25.4 |
比较例5 | IMPY | 0.8 |
实施例3 | 化合物1 | 1.1 |
实施例4 | 化合物2 | 30.5 |
实施例5 | 化合物3 | 36.6 |
实验 | 化合物 | logP辛醇值 |
比较例6 | [123I]-IMPY | 2.1 |
实施例6 | 化合物4 | 1.8 |
实验 | 用于评价的化合物 |
比较例7 | IMPY |
实施例7 | 化合物1 |
实施例8 | 化合物2 |
实施例9 | 化合物3 |
实验 | 化合物 | logPHPLC值 |
比较例7 | IMPY | 2.1 |
实施例7 | 化合物1 | 1.7 |
实施例8 | 化合物2 | 1.4 |
实施例9 | 化合物3 | 1.7 |
Claims (10)
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US80535606P | 2006-06-21 | 2006-06-21 | |
US60/805,356 | 2006-06-21 | ||
JP188034/2006 | 2006-07-07 | ||
JP2006188034 | 2006-07-07 | ||
PCT/JP2007/062503 WO2007148755A1 (ja) | 2006-06-21 | 2007-06-21 | 新規アミロイド親和性化合物 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN101501033A CN101501033A (zh) | 2009-08-05 |
CN101501033B true CN101501033B (zh) | 2012-08-01 |
Family
ID=38833493
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN2007800298930A Active CN101501033B (zh) | 2006-06-21 | 2007-06-21 | 对淀粉状蛋白具有亲和性的化合物 |
Country Status (10)
Country | Link |
---|---|
US (1) | US8277777B2 (zh) |
EP (1) | EP2042501B1 (zh) |
KR (1) | KR20090025282A (zh) |
CN (1) | CN101501033B (zh) |
AU (1) | AU2007261985B2 (zh) |
CA (1) | CA2655826A1 (zh) |
HK (1) | HK1133254A1 (zh) |
IL (1) | IL196046A0 (zh) |
NO (1) | NO20090233L (zh) |
WO (1) | WO2007148755A1 (zh) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TW200803903A (en) | 2006-04-28 | 2008-01-16 | Nihon Mediphysics Co Ltd | Novel compound having affinity to amyloid |
TW200808795A (en) | 2006-05-19 | 2008-02-16 | Nihon Mediphysics Co Ltd | Novel compound having affinity for amyloid |
NZ577511A (en) * | 2006-11-30 | 2012-04-27 | Nihon Mediphysics Co Ltd | 2-Phenyl-imidazo[1,2-a]pyridine derivatives substituted with a radioactive halogen substituent |
CN101903381A (zh) * | 2007-10-24 | 2010-12-01 | 日本医事物理股份有限公司 | 对淀粉样蛋白具有亲和性的新化合物 |
CA2704027A1 (en) * | 2007-10-26 | 2009-04-30 | Nihon Medi-Physics Co., Ltd. | Novel compound having affinity for amyloid |
EP2218464A1 (en) * | 2009-02-11 | 2010-08-18 | Technische Universität München | Compounds for non-invasive measurement of aggregates of amyloid peptides |
KR101123178B1 (ko) * | 2009-04-09 | 2012-06-13 | (주)에스메디 | 2-아릴벤조싸이오펜 유도체 또는 이의 약학적으로 허용가능한 염, 이의 제조방법 및 이를 유효성분으로 함유하는 퇴행성 뇌질환의 진단 또는 치료용 약학적 조성물 |
CN103596950B (zh) * | 2011-06-24 | 2017-12-19 | 日本医事物理股份有限公司 | 对淀粉状蛋白具有亲和性的化合物 |
JP6212628B2 (ja) * | 2013-04-29 | 2017-10-11 | エフ.ホフマン−ラ ロシュ アーゲーF. Hoffmann−La Roche Aktiengesellschaft | 2−フェニル又は2−ヘタリールイミダゾール[1,2−a]ピリジン誘導体 |
CN103724207B (zh) * | 2013-12-20 | 2016-07-06 | 北京智博高科生物技术有限公司 | 苯基苄基醚类衍生物及其制备方法和应用 |
WO2016033440A1 (en) * | 2014-08-29 | 2016-03-03 | Chdi Foundation, Inc. | Probes for imaging huntingtin protein |
US9926316B2 (en) * | 2016-03-03 | 2018-03-27 | The Cleveland Clinic Foundation | Antitumor derivatives for differentiation therapy |
CN108822105A (zh) * | 2018-08-14 | 2018-11-16 | 河南师范大学 | 一种由乙苯类化合物合成2-芳基咪唑并[1,2-a]吡啶类化合物的方法 |
Family Cites Families (30)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4871745A (en) | 1986-09-22 | 1989-10-03 | Ortho Pharmaceutical Corporation | 2- or 3-aryl substituted imidazo(1,2-A)pyridines and their use as antisecretory agents |
US4727145A (en) * | 1986-09-22 | 1988-02-23 | Ortho Pharmaceutical Corporation | 2- Or 3- aryl substituted imidazo [1,2-a]pyridines |
US4833149A (en) | 1986-09-22 | 1989-05-23 | Ortho Pharmaceutical Corporation | 2- or 3-aryl substituted imidazo[1,2-a]pyridines |
US4791117A (en) | 1986-09-22 | 1988-12-13 | Ortho Pharmaceutical Corporation | 2- or 3-aryl substituted imidazo[1,2-a]pyridines and their use as calcium channel blockers |
KR19990064310A (ko) | 1995-10-17 | 1999-07-26 | 윌리암스 로저 에이 | 시클로옥시게나제-2의 검출방법 |
US6812327B1 (en) | 1996-10-25 | 2004-11-02 | Human Genome Sciences, Inc. | Neutrokine-alpha polypeptides |
CA2340394A1 (en) | 1998-08-20 | 2000-03-02 | Jorge R. Barrio | Methods for labeling .beta.-amyloid plaques and neurofibrillary tangles |
JP4025468B2 (ja) | 1999-07-29 | 2007-12-19 | 三井化学株式会社 | 有機電界発光素子 |
WO2001074815A2 (en) | 2000-03-31 | 2001-10-11 | Ortho Mcneil Pharmaceutical, Inc. | Phenyl-substituted imidazopyridines |
US20010051632A1 (en) | 2000-03-31 | 2001-12-13 | Wenying Chai | Phenyl-substituted indolizines and tetrahydroindolizines |
AU2001249672A1 (en) * | 2000-03-31 | 2001-10-15 | Ortho-Mcneil Pharmaceutical, Inc. | Method for using 2- or 3-aryl substituted imidazo(1,2-a) pyridines as h3 antagonists |
US6514969B2 (en) | 2000-08-16 | 2003-02-04 | Boehringer Ingelheim Pharma Kg | β-amyloid inhibitors, processes for preparing them, and their use in pharmaceutical compositions |
DE10040016A1 (de) | 2000-08-16 | 2002-02-28 | Boehringer Ingelheim Pharma | Neue beta-Amyloid Inhibitoren, Verfahren zu deren Herstellung und deren Verwendung als Arzneimittel |
BRPI0113470B8 (pt) | 2000-08-24 | 2021-05-25 | Univ Pittsburgh | composto de ligação amilóide, composição farmacêutica e métodos de síntese de composto, de detecção in vivo de depósitos amilóides num indivíduo e em tecido humano ou animal, de quantificação de depósito amilóide em tecido de biópsia ou postmortem e de distinção de um cérebro de doença de alzheimer de um cérebro normal |
EP1365813A4 (en) | 2001-02-26 | 2006-03-22 | Bristol Myers Squibb Pharma Co | ASCORBIC ACID ANALOGUES FOR METALLORADIOPHARMACEUTICAL PRODUCTS |
US6596731B2 (en) | 2001-03-27 | 2003-07-22 | Hoffmann-La Roche Inc. | Substituted imidazo[1,2-A] pyridine derivatives |
DE60217090T2 (de) | 2001-04-23 | 2007-07-12 | The Trustees Of The University Of Pennsylvania | Amyloid plaque aggregationshemmer und diagnostische bilderzeugungsmittel |
EP1432453B1 (en) | 2001-08-27 | 2013-08-14 | The Trustees of The University of Pennsylvania | Stilbene derivatives and their use for binding and imaging amyloid plaques |
GB0205281D0 (en) | 2002-03-06 | 2002-04-17 | Novartis Ag | Organic compounds |
EP1356827A1 (en) | 2002-04-24 | 2003-10-29 | Mallinckrodt Inc. | Method for obtaining a 2-18F-fluor-2-deoxy-D-glucose (18F-FDG)-solution |
AU2003242233A1 (en) | 2002-06-12 | 2003-12-31 | Bf Research Institute, Inc. | Probe compound for image diagnosis of disease with amyloid accumulation, compound for staining age spots/diffuse age spots, and remedy for disease with amyloid accumulation |
JP2006505610A (ja) | 2002-11-05 | 2006-02-16 | イヨン ベアム アプリカスィヨン エッス.アー. | 18−f標識放射性製剤の安定化 |
GB0229695D0 (en) | 2002-12-20 | 2003-01-29 | Amersham Plc | Solid-phase preparation of 18F-labelled amino acids |
DE602004006536T2 (de) | 2003-12-31 | 2008-01-31 | Schering-Plough Ltd. | Bekämpfng von parasiten in tieren durch anwendung von imidazoä1,2-büpyridazinderivaten |
WO2007002540A2 (en) * | 2005-06-24 | 2007-01-04 | Kung Hank F | Radiolabeled-pegylation of ligands for use as imaging agents |
US20080219922A1 (en) * | 2005-09-12 | 2008-09-11 | Goodman Mark M | Alzheimer's Disease Imaging Agents |
TW200808795A (en) | 2006-05-19 | 2008-02-16 | Nihon Mediphysics Co Ltd | Novel compound having affinity for amyloid |
CN101903381A (zh) | 2007-10-24 | 2010-12-01 | 日本医事物理股份有限公司 | 对淀粉样蛋白具有亲和性的新化合物 |
CA2704027A1 (en) | 2007-10-26 | 2009-04-30 | Nihon Medi-Physics Co., Ltd. | Novel compound having affinity for amyloid |
CA2704139A1 (en) | 2007-10-30 | 2009-05-07 | Nihon Medi-Physics Co., Ltd. | Utilization of novel compounds with amyloid affinity and method of producing the same |
-
2007
- 2007-06-21 EP EP07767329.1A patent/EP2042501B1/en active Active
- 2007-06-21 KR KR1020087031662A patent/KR20090025282A/ko not_active Application Discontinuation
- 2007-06-21 AU AU2007261985A patent/AU2007261985B2/en not_active Expired - Fee Related
- 2007-06-21 US US12/308,715 patent/US8277777B2/en active Active
- 2007-06-21 CA CA002655826A patent/CA2655826A1/en not_active Abandoned
- 2007-06-21 WO PCT/JP2007/062503 patent/WO2007148755A1/ja active Application Filing
- 2007-06-21 CN CN2007800298930A patent/CN101501033B/zh active Active
-
2008
- 2008-12-18 IL IL196046A patent/IL196046A0/en unknown
-
2009
- 2009-01-14 NO NO20090233A patent/NO20090233L/no not_active Application Discontinuation
- 2009-12-03 HK HK09111320.9A patent/HK1133254A1/xx unknown
Also Published As
Publication number | Publication date |
---|---|
NO20090233L (no) | 2009-02-11 |
WO2007148755A1 (ja) | 2007-12-27 |
US8277777B2 (en) | 2012-10-02 |
EP2042501B1 (en) | 2017-04-12 |
CN101501033A (zh) | 2009-08-05 |
AU2007261985A1 (en) | 2007-12-27 |
EP2042501A1 (en) | 2009-04-01 |
AU2007261985B2 (en) | 2012-04-19 |
IL196046A0 (en) | 2009-09-01 |
US20100092387A1 (en) | 2010-04-15 |
EP2042501A4 (en) | 2012-11-21 |
HK1133254A1 (en) | 2010-03-19 |
KR20090025282A (ko) | 2009-03-10 |
CA2655826A1 (en) | 2007-12-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101501033B (zh) | 对淀粉状蛋白具有亲和性的化合物 | |
US8506930B2 (en) | Compounds having affinity for amyloid | |
CN101903383A (zh) | 对淀粉样蛋白具有亲和性的新化合物 | |
CN101903381A (zh) | 对淀粉样蛋白具有亲和性的新化合物 | |
US20110201808A1 (en) | Novel compound having affinity to amyloid | |
KR20100101577A (ko) | 신규 아밀로이드 친화성 화합물의 사용 및 제조 방법 | |
JP5180838B2 (ja) | 新規アミロイド親和性化合物 | |
EP2218463A1 (en) | Use of novel compound having affinity for amyloid, and process for production of the same | |
CN101535309A (zh) | 对淀粉状蛋白具有亲和性的新化合物 | |
CN102702195A (zh) | 对淀粉样蛋白具有亲和性的新化合物的应用及制备方法 | |
US20100249408A1 (en) | Use of novel compound having affinity for amyloid, and process for production of the same | |
CN101466711A (zh) | 对淀粉状蛋白具有亲和性的新化合物 | |
JP5247442B2 (ja) | 新規アミロイド親和性化合物 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
REG | Reference to a national code |
Ref country code: HK Ref legal event code: DE Ref document number: 1133254 Country of ref document: HK |
|
ASS | Succession or assignment of patent right |
Owner name: GE HEALTHCARE LTD. Free format text: FORMER OWNER: NIHON MEDI-PHYSICS CO., LTD. Effective date: 20120621 Free format text: FORMER OWNER: GE HEALTHCARE LTD. Effective date: 20120621 |
|
C41 | Transfer of patent application or patent right or utility model | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20120621 Address after: Buckinghamshire Applicant after: GE Healthcare Ltd. Address before: Tokyo, Japan Applicant before: Nihon Mediphysics Co., Ltd. Co-applicant before: GE Healthcare Ltd. |
|
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
REG | Reference to a national code |
Ref country code: HK Ref legal event code: GR Ref document number: 1133254 Country of ref document: HK |